Information  X 
Enter a valid email address

CIP Merchant Capital (CIP)

  Print      Mail a friend

Thursday 18 July, 2019

CIP Merchant Capital

Sixth Investment - Brave Bison Group plc

RNS Number : 0335G
CIP Merchant Capital Ltd
18 July 2019
 

18 July 2019

 

CIP MERCHANT CAPITAL LIMITED

("CIP Merchant Capital" or the "Company")

 

Sixth Investment - Brave Bison Group plc

 

CIP Merchant Capital is pleased to announce its investment in Brave Bison Group plc (AIM: BBSN) ("Brave Bison"), a social video company quoted on AIM market of the London Stock Exchange. The Company has acquired, in aggregate, 36,332,550 ordinary shares of 0.1p each in Brave Bison, representing approximately 5.97 per cent. of Brave Bison's issued share capital, for a total consideration of approximately £0.6 million.

 

In the year ended 31 December 2018, Brave Bison had revenues of £21.2 million, gross profit of £6.5 million, Adjusted EBITDA1 of £0.8 million, a net loss attributable to its shareholders of £71,000. As at 31 December 2018, Brave Bison had cash and cash equivalents of £5.4 million and net assets of £5.3 million. Currently, Brave Bison has a market capitalisation of approximately £11 million.

 

The investment constitutes the Company's sixth portfolio company.

 

 

 

 

[1] Adjusted EBITDA is earnings before interest, taxes, depreciation and amortisation and excludes restructuring costs and share-based payments.

 

 

 

For further information, please contact:

 

Merchant Capital Manager Limited (Investment Manager)

Marco Fumagalli

Carlo Sgarbi

 

+41 91 225 25 60

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

Richard Tulloch / James Bellman

+44 20 7409 3494

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACQRPMATMBMBBRL

a d v e r t i s e m e n t